title: Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome.
abstract: Current studies indicate that a thrombotic microangiopathy (TMA) identifies patients with systemic lupus erythematosus (SLE) who are at high risk of progressing to end-stage renal disease. We have observed two patients with SLE and one patient with a primary antiphospholipid syndrome (APS) who developed acute renal insufficiency with thrombocytopenia. Renal biopsies showed a TMA characterized by thrombi or by cellular and mucoid intimal hyperplasia of small arteries and arterioles. No arterial or arteriolar immune-complex deposits were detected by immunofluorescent or electron microscopy. Biopsies from one SLE patient and the APS patient showed no immune-complex glomerular disease. Both had serum antiphospholipid antibodies (aPL). aPL were not detected in the serum of the other SLE patient who had an active lupus nephritis. Acute renal failure and thrombocytopenia resolved in each case following treatment by plasmapheresis or prednisone and heparin. None of the patients were initially treated with cytotoxic drugs. As more knowledge is gained, the accurate identification of renal vascular lesions in SLE or related diseases could influence renal prognosis and choice of therapy. The cases reported here provide further evidence that a TMA can cause acute renal failure independent of lupus nephritis. TMA should be distinguished from other forms of renal vascular disease, particularly a noninflammatory lupus microangiopathy, which is probably mediated by subendothelial immune-complex deposits. The absence of immunoglobulin deposits in vessels involved by a TMA indicates that microvascular thrombosis is promoted by mechanisms other than those usually attributed to immune-complex disease. Phospholipid reactive antibodies may be pathogenetic in some cases.
authors.affiliation: Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City 73104.
authors.forename: M D
authors.initials: MD
authors.lastname: Hughson
authors.forename: T
authors.initials: T
authors.lastname: Nadasdy
authors.forename: G A
authors.initials: GA
authors.lastname: McCarty
authors.forename: C
authors.initials: C
authors.lastname: Sholer
authors.forename: K W
authors.initials: KW
authors.lastname: Min
authors.forename: F
authors.initials: F
authors.lastname: Silva
mesh_terms: D058186:Acute Kidney Injury / Q000209:etiology* / Q000473:pathology; D000293:Adolescent; D000328:Adult; D016736:Antiphospholipid Syndrome / Q000150:complications* / Q000473:pathology; D001706:Biopsy; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000473:pathology; D008297:Male; D012078:Renal Artery Obstruction / Q000150:complications / Q000209:etiology* / Q000473:pathology; D013927:Thrombosis / Q000150:complications / Q000209:etiology* / Q000473:pathology